France· FR:64511114
VORANIGO 10 mg, comprimé pelliculé
A medicinal product containing hemicitrate de vorasidénib hémihydraté, registered in France by LES LABORATOIRES SERVIER.
Checked against Base de données publique des médicaments — BDPM (France) on
Informational only — not a medical device.
The record
At a glance
Base de données publique des médicaments — BDPM (France)- Active substance
- HEMICITRATE DE VORASIDÉNIB HÉMIHYDRATÉ
- Manufacturer
- LES LABORATOIRES SERVIER
- Country
- France (FR)
- ATC code
- —
- Reimbursed
- No
- Source register
- Base de données publique des médicaments — BDPM (France)
- Last checked
- September 12, 2026
Packs & prices · 1
- cip1334009303108781 flacon(s) polyéthylène haute densité (PEHD) avec fermeture de sécurité enfant de 30 comprimé(s)
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Same medicine, other countries
Hemicitrate de vorasidénib hémihydraté in 9 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- United StatesVORANIGOServier Pharmaceuticals LLC
- SpainVORANIGO 10 MG COMPRIMIDOS RECUBIERTOS CON PELICULALes Laboratoires Servier
- NetherlandsVoranigo 10 mg filmomhulde tablettenLes Laboratoires Servier
- SwitzerlandVoranigo 10 mg, comprimés pelliculésServier (Suisse) SA
- PolandVoranigoLes Laboratoires Servier
- SwedenVoranigo 10 mg Filmdragerad tablettLes Laboratoires Servier
- NorwayVoranigoLes Laboratoires Servier
- United KingdomVoranigo 10mg tabletsServier Laboratories Ltd
Authorised across Europe · EMA
The same active substance is authorised in 3 EEA countries. Names it is sold under:
- Iceland · Voranigo
- Liechtenstein · Voranigo
- Norway · Voranigo
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of Base de données publique des médicaments — BDPM (France). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/d93aea9e-6143-4c6f-b02c-8315b3dc5fd8 GET /v1/drugs/d93aea9e-6143-4c6f-b02c-8315b3dc5fd8?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"cis": "64511114",
"date_amm": "2025-09-17",
"type_amm": "Procédure centralisée",
"numero_ue": "EU/1/25/1912",
"substance": "HEMICITRATE DE VORASIDÉNIB HÉMIHYDRATÉ",
"statut_amm": "Autorisation active",
"statut_bdm": null,
"forme_pharmaceutique": "comprimé pelliculé",
"voies_administration": "orale",
"etat_commercialisation": "Commercialisée",
"surveillance_renforcee": "Oui"
}See everything about hemicitrate de vorasidénib hémihydraté.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.